News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current PMN market cap is 420M. The company's latest EPS is USD -0.1887 and P/E is -0.53.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1,000 | 2k | 0 | 0 | 0 |
| Operating Income | -7.36M | -5.68M | -8.29M | -23.38M | -14.26M |
| Net Income | -7.4M | -5.66M | -9.79M | -18.06M | -13.21M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.07M | 1.39M | 17.75M | 6.93M | 13.62M |
| Total Liabilities | 1.68M | 2.4M | 12.09M | 8.27M | 9.87M |
| Total Equity | 398k | -1.02M | 5.66M | -1.35M | 3.75M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.09M | -4.36M | -9.31M | -17.03M | -10.84M |
| Investing | N/A | -112k | 95k | -2k | -1,000 |
| Financing | 5.36M | 3.83M | 25.52M | 6.49M | 17.75M |
| Market Cap | 420M |
| Price to Earnings Ratio | -0.53 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.56 |
| Price to Book Ratio | 1.87 |
| Dividend Yield | - |
| Shares Outstanding | 70M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -15.49% |
| 52 Week High | 10.50 |
| 52 Week Low | 3.34 |
| Spread (Intraday) | 2.9 (33.14%) |
| Company Name | ProMIS Neurosciences Inc |
| Address |
suite 200 toronto, ontario M4S 3E2 |
| Website | https://www.promisneurosciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
